{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:15Z","timestamp":1792180695543,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002187.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":49,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002187.pub3","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T14:23:19Z","timestamp":1170771799000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus"],"prefix":"10.1002","volume":"2009","author":[{"given":"Moshe","family":"Vardi","sequence":"first","affiliation":[{"name":"Carmel Medical Center; Internal Medicine;  7 Michal St, Haifa Haifa Israel 34362"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaph","family":"Nini","sequence":"additional","affiliation":[{"name":"Sheba Medical Center; Intensive Care Unit; 2 Sheba Rd Tel Hashomer Israel 52661"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD002187.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s001250100656","article-title":"Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus","volume":"44","author":"Boulton","year":"2001","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0002|cit2","first-page":"121","article-title":"Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction","volume":"119","author":"Escobar-Jimenez","year":"2002","journal-title":"Medicina cl\u00ednica"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P","article-title":"Sildenafil: study of novel oral treatment for erectile dysfunction in diabetic men","volume":"15","author":"Price","year":"1998","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","article-title":"Effects of tadalafil on erectile dysfunction in men with diabetes","volume":"25","author":"Saenz de Tejada","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1056-8727(03)00056-4","article-title":"Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study","volume":"18","author":"Safarinejad","year":"2004","journal-title":"Diabetes Complications"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/diacare.26.2.279","article-title":"Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial","volume":"26","author":"Stuckey","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.ijir.3901302","article-title":"Sildenafil in the treatment of erectile dysfunction in men with diabetes: demand, efficacy and patient satisfaction","volume":"17","author":"Behrend","year":"2005","journal-title":"International Journal of Impotence Research"},{"issue":"2","key":"10.1002\/14651858.CD002187.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.urology.2004.09.056","article-title":"Efficacy, safety, and treatment satisfaction of Tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers","volume":"65","author":"Carson","year":"2005","journal-title":"Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2004.06.005","article-title":"Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes","volume":"46","author":"El-Sakka","year":"2004","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s00125-004-1549-6","article-title":"Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analyses of data from tadaladil clinical trials","volume":"47","author":"Fonseka","year":"2004","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0013|cit13","first-page":"78","article-title":"Sildenafil citrate (Viagra) treatment in patients with diabetes","volume":"71","author":"Kalinchenko","year":"1999","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000049769","article-title":"Sildenafil: efficacy and safety in daily clinical experience","volume":"40","author":"Palumbo","year":"2001","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0302-2838(02)00032-5","article-title":"Switching from lomg-term treatment with self-injections to oral sildenafil in diabetic patients with sever erectile dysfunction","volume":"41","author":"Perimenis","year":"2002","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.ijir.3901203","article-title":"Nocturnal electrobioimpedence volumetric assessment in diabetic men with erectle dysfunction before and after Tadalafil intake","volume":"16","author":"Salama","year":"2004","journal-title":"International Journal of Impotence Research"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.ijir.3900910","article-title":"Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus","volume":"14","author":"Vickers","year":"2002","journal-title":"International Journal of Impotence Research"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0018|cit18","first-page":"S5","article-title":"Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20 Suppl 1","author":"American Diabetes Association","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"191\u2013236","DOI":"10.1152\/physrev.1995.75.1.191","article-title":"Physiology of penile erection","volume":"75","author":"Andersson","year":"1995","journal-title":"Physiological Reviews"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/sj.ijir.3901213","article-title":"Vardenafil preclinical trial data potency, pharmacodynamics, pharmacokinetics, and adverse events","volume":"16","author":"Bischoff","year":"2004","journal-title":"Interational Journal of Impotence Research"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"727\u201345","DOI":"10.1016\/S0094-0143(21)00692-3","article-title":"The penis as a vascular organ: the importance of corporal smooth muscle tone in the control of erection","volume":"22","author":"Christ","year":"1995","journal-title":"Urologic Clinics of North America"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0022|cit22","unstructured":"Cialis (tadalafil) prescribing information Cialis (tadalafil) prescribing information. Indianapolis, IN, and Bothell, WA: Lilly ICOS LLC, 2003"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"37M","DOI":"10.1016\/j.amjcard.2005.07.010","article-title":"Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors","volume":"96","author":"Culley","year":"2005","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.ijir.3900269","article-title":"On life satisfaction in male erectile dysfunction","volume":"9","author":"Fugl-Meyer","year":"1997","journal-title":"International journal of impotence research"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1397\u2013404","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group","volume":"338","author":"Goldstein","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0029|cit29","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","article-title":"Incidence of erectile dysfunction in men ages 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study","volume":"163","author":"Johannes","year":"2000","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/S0002-9149(03)00075-4","article-title":"Cardiovascular effects of tadalafil in patients on common antihypertensive therapies","volume":"92","author":"Kloner","year":"2003","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"I20","DOI":"10.1002\/clc.4960271306","article-title":"Novel phosphodiesterase type 5 inhibitors assessing hemodynamic effects and safety parameters","volume":"27","author":"Kloner","year":"2004","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0034|cit34","unstructured":"Levitra (vardenafil) prescribing information Levitra (vardenafil) prescribing information. West Haven, CT: Bayer Pharmaceutical Corporation 2003"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0035|cit35","first-page":"28\u201338","article-title":"Hemodynamics of erection","volume-title":"Contemporary Management of Impotence and Infertility","author":"Lue","year":"1988"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0036|cit36","first-page":"1802\u201313","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"New England Jounal of Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1\u20136","DOI":"10.3181\/00379727-211-43950A","article-title":"Nitric oxide and cyclic GMP signaling","volume":"211","author":"McDonald","year":"1996","journal-title":"Experimental Biology and Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1742-1241.2003.tb10566.x","article-title":"Clinical trials of sildenafil citrate (Viagra) demonstrates no increase in risk of myocardial infarction and cardiovascular death compared with placebo","volume":"57","author":"MA","year":"2003","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0039|cit39","first-page":"424\u201331","article-title":"Endogenous neurotransmitters mediating penile erection","volume":"81","author":"Naylor","year":"1998","journal-title":"British Journal of Urology International"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"709\u201321","DOI":"10.4065\/74.7.709","article-title":"Pharmacotherapeutic advances in the treatment of erectile dysfunction","volume":"74","author":"Nehra","year":"1999","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence JAMA 1993 83 90","DOI":"10.1001\/jama.1993.03510010089036"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"90\u20134","DOI":"10.1056\/NEJM199201093260203","article-title":"Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission","volume":"326","author":"Rajfer","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF)","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"237","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0045|cit45","first-page":"108","article-title":"Erectile dysfunction in diabetes: pills for penile failure","volume":"16","author":"Vinik","year":"1998","journal-title":"Clinical Diabetes"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0046|cit46","first-page":"16","article-title":"Erectile dysfunction in diabetes","volume":"6","author":"Vinik","year":"1998","journal-title":"Diabetes Reviews"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0047|cit47","unstructured":"WHO Expert Committee on Diabetes Mellitus World Health Organization, 1985. Technical Report Series 727"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD002187.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"35C","DOI":"10.1016\/S0002-9149(99)00046-6","article-title":"Overall cardiovascular profile of sildenafil citrate profile of sildenafil citrate","volume":"83 Suppl","author":"Zusman","year":"1999","journal-title":"American Journal of cardiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002187.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:31:46Z","timestamp":1792179106000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002187.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Metabolic and Endocrine Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002187.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}